Information  X 
Enter a valid email address

Lipoxen PLC (XEN)

  Print      Mail a friend

Friday 31 October, 2008

Lipoxen PLC

Director/PDMR Shareholding an

RNS Number : 0954H
Lipoxen PLC
31 October 2008

Lipoxen plc 

('Lipoxen' or the 'Company')

Director dealings and Total Voting Rights

The Company was informed on 30 October that on 29 September Sir Brian Richards acquired 250,000 ordinary shares of 0.5p each ('Ordinary Shares') at 11.5 pence each

Following this acquisition Sir Brian Richards has an interest in Lipoxen of 250,000Ordinary Shares, representing 0.21 per cent of the issued Ordinary Share capital in the Company.

Also, in conformity with the FSA's Disclosure and Transparency Rules, the Company notifies the market of the following:

Lipoxen's capital consists of 119,858,085 ordinary shares of 0.5p each ('Ordinary Shares') with voting rights. No Ordinary Shares are held in treasury, therefore the total number of voting rights in the Company is 119,858,085.

The above figure (119,858,085) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Lipoxen under the FSA's Disclosure and Transparency Rules.


Lipoxen plc

+44 (0)20 7691 3583

Scott Maguire, Chief Executive Director

Colin Hill, Finance Director

Teathers Limited 

(nominated adviser)

+44 (0)20 7426 9000

Shaun Dobson / Claes Spång

Citigate Dewe Rogerson

+44 (0)20 7638 9571

David Dible / Heather Keohane

This information is provided by RNS
The company news service from the London Stock Exchange